Evaluating long-term effectiveness of neurostimulation therapy for pain

A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Observational Boston Scientific Corporation · NCT01719055

This study is testing how well Boston Scientific's neurostimulation therapy works for managing pain over the long term in people who have had a positive trial with the treatment.

Quick facts

Study typeObservational
Enrollment4800 (estimated)
Ages18 Years and up
SexAll
SponsorBoston Scientific Corporation Industry-sponsored
Locations118 sites (Phoenix, Arizona and 117 other locations)
Trial IDNCT01719055 on ClinicalTrials.gov

What this trial studies

This study is a global, prospective observational registry that aims to gather real-world clinical outcomes of Boston Scientific's neurostimulation systems for pain management. It will assess the long-term effectiveness, economic value, and technical performance of these systems when used in routine clinical practice. Participants who respond positively to a trial of the neurostimulation therapy may receive a permanent implant, with treatment tailored to individual patient needs based on clinical discretion. The study will involve multiple centers and will adhere to established inclusion and exclusion criteria.

Who should consider this trial

Good fit: Ideal candidates are adults aged 18 and older who are scheduled to trial a commercially approved Boston Scientific neurostimulation system for pain.

Not a fit: Patients with contraindications for the neurostimulation system or those with cognitive impairments that affect their ability to assess pain relief will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness of neurostimulation therapy, potentially improving pain management strategies for patients.

How similar studies have performed: Other studies have shown success with similar neurostimulation approaches, indicating a promising avenue for pain management.

Eligibility criteria

Show full inclusion / exclusion criteria
Key Inclusion Criteria:

* Study candidate is scheduled to be trialed, on-label, with a commercially approved Boston Scientific neurostimulation system for pain, per local directions for use
* Signed a valid, IRB/EC-approved informed consent form
* 18 years of age or older

Key Exclusion Criteria:

* Contraindicated for Boston Scientific neurostimulation system
* Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments

Where this trial is running

Phoenix, Arizona and 117 other locations

+68 more sites — see ClinicalTrials.gov for the full list.

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Painstimulationimplantablepulse generatorback painchronic painleg pain
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.